カテゴリ： 世界, 部品/材料, Market Monitor Global

ポリペプチドAPIのグローバル市場展望 2023年-2029年：インスリン、非インスリン

■ 英語タイトル：Polypeptide API Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC15099）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC15099
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：化学＆材料
■ ページ数：115
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ポリペプチドAPIのグローバル市場展望 2023年-2029年：インスリン、非インスリン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のポリペプチドAPI市場規模と予測を収録しています。・世界のポリペプチドAPI市場：売上、2018年-2023年、2024年-2029年
・世界のポリペプチドAPI市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のポリペプチドAPI市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「インスリン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ポリペプチドAPIのグローバル主要企業は、Ambio Pharmaceuticals、 Jiangsu Sinopep Allsin Bphrmctcl、 Chengdu Shengnuo Biotechnology、 Hybio Pharmaceutical、 Hainan Shuangcheng、 Zhejiang Paitai Biology、 Hefei KS-V Peptide Biological Technology、 JYMedtech、 GenScript、 Chinese Peptide、 Asymchem Lab、 Aurisco Pharmaceutical、 BrightGene Bio-Medical Technology、 WuXi AppTec、 Spera Nexusなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ポリペプチドAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のポリペプチドAPI市場：タイプ別、2018年-2023年、2024年-2029年
世界のポリペプチドAPI市場：タイプ別市場シェア、2022年
・インスリン、非インスリン

世界のポリペプチドAPI市場：用途別、2018年-2023年、2024年-2029年
世界のポリペプチドAPI市場：用途別市場シェア、2022年
・医薬品、化粧品、その他

世界のポリペプチドAPI市場：地域・国別、2018年-2023年、2024年-2029年
世界のポリペプチドAPI市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるポリペプチドAPIのグローバル売上、2018年-2023年
・主要企業におけるポリペプチドAPIのグローバル売上シェア、2022年
・主要企業におけるポリペプチドAPIのグローバル販売量、2018年-2023年
・主要企業におけるポリペプチドAPIのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Ambio Pharmaceuticals、 Jiangsu Sinopep Allsin Bphrmctcl、 Chengdu Shengnuo Biotechnology、 Hybio Pharmaceutical、 Hainan Shuangcheng、 Zhejiang Paitai Biology、 Hefei KS-V Peptide Biological Technology、 JYMedtech、 GenScript、 Chinese Peptide、 Asymchem Lab、 Aurisco Pharmaceutical、 BrightGene Bio-Medical Technology、 WuXi AppTec、 Spera Nexus

*************************************************************

・調査・分析レポートの概要
ポリペプチドAPI市場の定義
市場セグメント
世界のポリペプチドAPI市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のポリペプチドAPI市場規模
世界のポリペプチドAPI市場規模：2022年 VS 2029年
世界のポリペプチドAPI市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのポリペプチドAPIの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のポリペプチドAPI製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：インスリン、非インスリン
ポリペプチドAPIのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医薬品、化粧品、その他
ポリペプチドAPIの用途別グローバル売上・予測

・地域別市場分析
地域別ポリペプチドAPI市場規模 2022年と2029年
地域別ポリペプチドAPI売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Ambio Pharmaceuticals、 Jiangsu Sinopep Allsin Bphrmctcl、 Chengdu Shengnuo Biotechnology、 Hybio Pharmaceutical、 Hainan Shuangcheng、 Zhejiang Paitai Biology、 Hefei KS-V Peptide Biological Technology、 JYMedtech、 GenScript、 Chinese Peptide、 Asymchem Lab、 Aurisco Pharmaceutical、 BrightGene Bio-Medical Technology、 WuXi AppTec、 Spera Nexus
...

This research report provides a comprehensive analysis of the Polypeptide API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Polypeptide API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Polypeptide API, challenges faced by the industry, and potential opportunities for market players.
The global Polypeptide API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Polypeptide API market presents opportunities for various stakeholders, including Pharmaceutical, Cosmetic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Polypeptide API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Polypeptide API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Polypeptide API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Polypeptide API market.
Market Overview: The report provides a comprehensive overview of the Polypeptide API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Insulin Type, Non-Insulin Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Polypeptide API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Polypeptide API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Polypeptide API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Polypeptide API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Polypeptide API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Polypeptide API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Polypeptide API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Polypeptide API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Polypeptide API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Insulin Type
Non-Insulin Type
Market segment by Application
Pharmaceutical
Cosmetic
Other
Global Polypeptide API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Ambio Pharmaceuticals
Jiangsu Sinopep Allsin Bphrmctcl
Chengdu Shengnuo Biotechnology
Hybio Pharmaceutical
Hainan Shuangcheng
Zhejiang Paitai Biology
Hefei KS-V Peptide Biological Technology
JYMedtech
GenScript
Chinese Peptide
Asymchem Lab
Aurisco Pharmaceutical
BrightGene Bio-Medical Technology
WuXi AppTec
Spera Nexus
Outline of Major Chapters:
Chapter 1: Introduces the definition of Polypeptide API, market overview.
Chapter 2: Global Polypeptide API market size in revenue and volume.
Chapter 3: Detailed analysis of Polypeptide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polypeptide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Polypeptide API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Polypeptide API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polypeptide API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polypeptide API Overall Market Size
2.1 Global Polypeptide API Market Size: 2022 VS 2029
2.2 Global Polypeptide API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Polypeptide API Sales: 2018-2029
3 Company Landscape
3.1 Top Polypeptide API Players in Global Market
3.2 Top Global Polypeptide API Companies Ranked by Revenue
3.3 Global Polypeptide API Revenue by Companies
3.4 Global Polypeptide API Sales by Companies
3.5 Global Polypeptide API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Polypeptide API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Polypeptide API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polypeptide API Players in Global Market
3.8.1 List of Global Tier 1 Polypeptide API Companies
3.8.2 List of Global Tier 2 and Tier 3 Polypeptide API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Polypeptide API Market Size Markets, 2022 & 2029
4.1.2 Insulin Type
4.1.3 Non-Insulin Type
4.2 By Type – Global Polypeptide API Revenue & Forecasts
4.2.1 By Type – Global Polypeptide API Revenue, 2018-2023
4.2.2 By Type – Global Polypeptide API Revenue, 2024-2029
4.2.3 By Type – Global Polypeptide API Revenue Market Share, 2018-2029
4.3 By Type – Global Polypeptide API Sales & Forecasts
4.3.1 By Type – Global Polypeptide API Sales, 2018-2023
4.3.2 By Type – Global Polypeptide API Sales, 2024-2029
4.3.3 By Type – Global Polypeptide API Sales Market Share, 2018-2029
4.4 By Type – Global Polypeptide API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Polypeptide API Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Cosmetic
5.1.4 Other
5.2 By Application – Global Polypeptide API Revenue & Forecasts
5.2.1 By Application – Global Polypeptide API Revenue, 2018-2023
5.2.2 By Application – Global Polypeptide API Revenue, 2024-2029
5.2.3 By Application – Global Polypeptide API Revenue Market Share, 2018-2029
5.3 By Application – Global Polypeptide API Sales & Forecasts
5.3.1 By Application – Global Polypeptide API Sales, 2018-2023
5.3.2 By Application – Global Polypeptide API Sales, 2024-2029
5.3.3 By Application – Global Polypeptide API Sales Market Share, 2018-2029
5.4 By Application – Global Polypeptide API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Polypeptide API Market Size, 2022 & 2029
6.2 By Region – Global Polypeptide API Revenue & Forecasts
6.2.1 By Region – Global Polypeptide API Revenue, 2018-2023
6.2.2 By Region – Global Polypeptide API Revenue, 2024-2029
6.2.3 By Region – Global Polypeptide API Revenue Market Share, 2018-2029
6.3 By Region – Global Polypeptide API Sales & Forecasts
6.3.1 By Region – Global Polypeptide API Sales, 2018-2023
6.3.2 By Region – Global Polypeptide API Sales, 2024-2029
6.3.3 By Region – Global Polypeptide API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Polypeptide API Revenue, 2018-2029
6.4.2 By Country – North America Polypeptide API Sales, 2018-2029
6.4.3 US Polypeptide API Market Size, 2018-2029
6.4.4 Canada Polypeptide API Market Size, 2018-2029
6.4.5 Mexico Polypeptide API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Polypeptide API Revenue, 2018-2029
6.5.2 By Country – Europe Polypeptide API Sales, 2018-2029
6.5.3 Germany Polypeptide API Market Size, 2018-2029
6.5.4 France Polypeptide API Market Size, 2018-2029
6.5.5 U.K. Polypeptide API Market Size, 2018-2029
6.5.6 Italy Polypeptide API Market Size, 2018-2029
6.5.7 Russia Polypeptide API Market Size, 2018-2029
6.5.8 Nordic Countries Polypeptide API Market Size, 2018-2029
6.5.9 Benelux Polypeptide API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Polypeptide API Revenue, 2018-2029
6.6.2 By Region – Asia Polypeptide API Sales, 2018-2029
6.6.3 China Polypeptide API Market Size, 2018-2029
6.6.4 Japan Polypeptide API Market Size, 2018-2029
6.6.5 South Korea Polypeptide API Market Size, 2018-2029
6.6.6 Southeast Asia Polypeptide API Market Size, 2018-2029
6.6.7 India Polypeptide API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Polypeptide API Revenue, 2018-2029
6.7.2 By Country – South America Polypeptide API Sales, 2018-2029
6.7.3 Brazil Polypeptide API Market Size, 2018-2029
6.7.4 Argentina Polypeptide API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Polypeptide API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Polypeptide API Sales, 2018-2029
6.8.3 Turkey Polypeptide API Market Size, 2018-2029
6.8.4 Israel Polypeptide API Market Size, 2018-2029
6.8.5 Saudi Arabia Polypeptide API Market Size, 2018-2029
6.8.6 UAE Polypeptide API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ambio Pharmaceuticals
7.1.1 Ambio Pharmaceuticals Company Summary
7.1.2 Ambio Pharmaceuticals Business Overview
7.1.3 Ambio Pharmaceuticals Polypeptide API Major Product Offerings
7.1.4 Ambio Pharmaceuticals Polypeptide API Sales and Revenue in Global (2018-2023)
7.1.5 Ambio Pharmaceuticals Key News & Latest Developments
7.2 Jiangsu Sinopep Allsin Bphrmctcl
7.2.1 Jiangsu Sinopep Allsin Bphrmctcl Company Summary
7.2.2 Jiangsu Sinopep Allsin Bphrmctcl Business Overview
7.2.3 Jiangsu Sinopep Allsin Bphrmctcl Polypeptide API Major Product Offerings
7.2.4 Jiangsu Sinopep Allsin Bphrmctcl Polypeptide API Sales and Revenue in Global (2018-2023)
7.2.5 Jiangsu Sinopep Allsin Bphrmctcl Key News & Latest Developments
7.3 Chengdu Shengnuo Biotechnology
7.3.1 Chengdu Shengnuo Biotechnology Company Summary
7.3.2 Chengdu Shengnuo Biotechnology Business Overview
7.3.3 Chengdu Shengnuo Biotechnology Polypeptide API Major Product Offerings
7.3.4 Chengdu Shengnuo Biotechnology Polypeptide API Sales and Revenue in Global (2018-2023)
7.3.5 Chengdu Shengnuo Biotechnology Key News & Latest Developments
7.4 Hybio Pharmaceutical
7.4.1 Hybio Pharmaceutical Company Summary
7.4.2 Hybio Pharmaceutical Business Overview
7.4.3 Hybio Pharmaceutical Polypeptide API Major Product Offerings
7.4.4 Hybio Pharmaceutical Polypeptide API Sales and Revenue in Global (2018-2023)
7.4.5 Hybio Pharmaceutical Key News & Latest Developments
7.5 Hainan Shuangcheng
7.5.1 Hainan Shuangcheng Company Summary
7.5.2 Hainan Shuangcheng Business Overview
7.5.3 Hainan Shuangcheng Polypeptide API Major Product Offerings
7.5.4 Hainan Shuangcheng Polypeptide API Sales and Revenue in Global (2018-2023)
7.5.5 Hainan Shuangcheng Key News & Latest Developments
7.6 Zhejiang Paitai Biology
7.6.1 Zhejiang Paitai Biology Company Summary
7.6.2 Zhejiang Paitai Biology Business Overview
7.6.3 Zhejiang Paitai Biology Polypeptide API Major Product Offerings
7.6.4 Zhejiang Paitai Biology Polypeptide API Sales and Revenue in Global (2018-2023)
7.6.5 Zhejiang Paitai Biology Key News & Latest Developments
7.7 Hefei KS-V Peptide Biological Technology
7.7.1 Hefei KS-V Peptide Biological Technology Company Summary
7.7.2 Hefei KS-V Peptide Biological Technology Business Overview
7.7.3 Hefei KS-V Peptide Biological Technology Polypeptide API Major Product Offerings
7.7.4 Hefei KS-V Peptide Biological Technology Polypeptide API Sales and Revenue in Global (2018-2023)
7.7.5 Hefei KS-V Peptide Biological Technology Key News & Latest Developments
7.8 JYMedtech
7.8.1 JYMedtech Company Summary
7.8.2 JYMedtech Business Overview
7.8.3 JYMedtech Polypeptide API Major Product Offerings
7.8.4 JYMedtech Polypeptide API Sales and Revenue in Global (2018-2023)
7.8.5 JYMedtech Key News & Latest Developments
7.9 GenScript
7.9.1 GenScript Company Summary
7.9.2 GenScript Business Overview
7.9.3 GenScript Polypeptide API Major Product Offerings
7.9.4 GenScript Polypeptide API Sales and Revenue in Global (2018-2023)
7.9.5 GenScript Key News & Latest Developments
7.10 Chinese Peptide
7.10.1 Chinese Peptide Company Summary
7.10.2 Chinese Peptide Business Overview
7.10.3 Chinese Peptide Polypeptide API Major Product Offerings
7.10.4 Chinese Peptide Polypeptide API Sales and Revenue in Global (2018-2023)
7.10.5 Chinese Peptide Key News & Latest Developments
7.11 Asymchem Lab
7.11.1 Asymchem Lab Company Summary
7.11.2 Asymchem Lab Business Overview
7.11.3 Asymchem Lab Polypeptide API Major Product Offerings
7.11.4 Asymchem Lab Polypeptide API Sales and Revenue in Global (2018-2023)
7.11.5 Asymchem Lab Key News & Latest Developments
7.12 Aurisco Pharmaceutical
7.12.1 Aurisco Pharmaceutical Company Summary
7.12.2 Aurisco Pharmaceutical Business Overview
7.12.3 Aurisco Pharmaceutical Polypeptide API Major Product Offerings
7.12.4 Aurisco Pharmaceutical Polypeptide API Sales and Revenue in Global (2018-2023)
7.12.5 Aurisco Pharmaceutical Key News & Latest Developments
7.13 BrightGene Bio-Medical Technology
7.13.1 BrightGene Bio-Medical Technology Company Summary
7.13.2 BrightGene Bio-Medical Technology Business Overview
7.13.3 BrightGene Bio-Medical Technology Polypeptide API Major Product Offerings
7.13.4 BrightGene Bio-Medical Technology Polypeptide API Sales and Revenue in Global (2018-2023)
7.13.5 BrightGene Bio-Medical Technology Key News & Latest Developments
7.14 WuXi AppTec
7.14.1 WuXi AppTec Company Summary
7.14.2 WuXi AppTec Business Overview
7.14.3 WuXi AppTec Polypeptide API Major Product Offerings
7.14.4 WuXi AppTec Polypeptide API Sales and Revenue in Global (2018-2023)
7.14.5 WuXi AppTec Key News & Latest Developments
7.15 Spera Nexus
7.15.1 Spera Nexus Company Summary
7.15.2 Spera Nexus Business Overview
7.15.3 Spera Nexus Polypeptide API Major Product Offerings
7.15.4 Spera Nexus Polypeptide API Sales and Revenue in Global (2018-2023)
7.15.5 Spera Nexus Key News & Latest Developments
8 Global Polypeptide API Production Capacity, Analysis
8.1 Global Polypeptide API Production Capacity, 2018-2029
8.2 Polypeptide API Production Capacity of Key Manufacturers in Global Market
8.3 Global Polypeptide API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polypeptide API Supply Chain Analysis
10.1 Polypeptide API Industry Value Chain
10.2 Polypeptide API Upstream Market
10.3 Polypeptide API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polypeptide API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Polypeptide API in Global Market
Table 2. Top Polypeptide API Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Polypeptide API Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Polypeptide API Revenue Share by Companies, 2018-2023
Table 5. Global Polypeptide API Sales by Companies, (Tons), 2018-2023
Table 6. Global Polypeptide API Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Polypeptide API Price (2018-2023) & (US$/Kg)
Table 8. Global Manufacturers Polypeptide API Product Type
Table 9. List of Global Tier 1 Polypeptide API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polypeptide API Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Polypeptide API Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Polypeptide API Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Polypeptide API Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Polypeptide API Sales (Tons), 2018-2023
Table 15. By Type - Global Polypeptide API Sales (Tons), 2024-2029
Table 16. By Application – Global Polypeptide API Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Polypeptide API Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Polypeptide API Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Polypeptide API Sales (Tons), 2018-2023
Table 20. By Application - Global Polypeptide API Sales (Tons), 2024-2029
Table 21. By Region – Global Polypeptide API Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Polypeptide API Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Polypeptide API Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Polypeptide API Sales (Tons), 2018-2023
Table 25. By Region - Global Polypeptide API Sales (Tons), 2024-2029
Table 26. By Country - North America Polypeptide API Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Polypeptide API Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Polypeptide API Sales, (Tons), 2018-2023
Table 29. By Country - North America Polypeptide API Sales, (Tons), 2024-2029
Table 30. By Country - Europe Polypeptide API Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Polypeptide API Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Polypeptide API Sales, (Tons), 2018-2023
Table 33. By Country - Europe Polypeptide API Sales, (Tons), 2024-2029
Table 34. By Region - Asia Polypeptide API Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Polypeptide API Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Polypeptide API Sales, (Tons), 2018-2023
Table 37. By Region - Asia Polypeptide API Sales, (Tons), 2024-2029
Table 38. By Country - South America Polypeptide API Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Polypeptide API Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Polypeptide API Sales, (Tons), 2018-2023
Table 41. By Country - South America Polypeptide API Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Polypeptide API Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Polypeptide API Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Polypeptide API Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Polypeptide API Sales, (Tons), 2024-2029
Table 46. Ambio Pharmaceuticals Company Summary
Table 47. Ambio Pharmaceuticals Polypeptide API Product Offerings
Table 48. Ambio Pharmaceuticals Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 49. Ambio Pharmaceuticals Key News & Latest Developments
Table 50. Jiangsu Sinopep Allsin Bphrmctcl Company Summary
Table 51. Jiangsu Sinopep Allsin Bphrmctcl Polypeptide API Product Offerings
Table 52. Jiangsu Sinopep Allsin Bphrmctcl Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 53. Jiangsu Sinopep Allsin Bphrmctcl Key News & Latest Developments
Table 54. Chengdu Shengnuo Biotechnology Company Summary
Table 55. Chengdu Shengnuo Biotechnology Polypeptide API Product Offerings
Table 56. Chengdu Shengnuo Biotechnology Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 57. Chengdu Shengnuo Biotechnology Key News & Latest Developments
Table 58. Hybio Pharmaceutical Company Summary
Table 59. Hybio Pharmaceutical Polypeptide API Product Offerings
Table 60. Hybio Pharmaceutical Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 61. Hybio Pharmaceutical Key News & Latest Developments
Table 62. Hainan Shuangcheng Company Summary
Table 63. Hainan Shuangcheng Polypeptide API Product Offerings
Table 64. Hainan Shuangcheng Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 65. Hainan Shuangcheng Key News & Latest Developments
Table 66. Zhejiang Paitai Biology Company Summary
Table 67. Zhejiang Paitai Biology Polypeptide API Product Offerings
Table 68. Zhejiang Paitai Biology Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 69. Zhejiang Paitai Biology Key News & Latest Developments
Table 70. Hefei KS-V Peptide Biological Technology Company Summary
Table 71. Hefei KS-V Peptide Biological Technology Polypeptide API Product Offerings
Table 72. Hefei KS-V Peptide Biological Technology Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 73. Hefei KS-V Peptide Biological Technology Key News & Latest Developments
Table 74. JYMedtech Company Summary
Table 75. JYMedtech Polypeptide API Product Offerings
Table 76. JYMedtech Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 77. JYMedtech Key News & Latest Developments
Table 78. GenScript Company Summary
Table 79. GenScript Polypeptide API Product Offerings
Table 80. GenScript Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 81. GenScript Key News & Latest Developments
Table 82. Chinese Peptide Company Summary
Table 83. Chinese Peptide Polypeptide API Product Offerings
Table 84. Chinese Peptide Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 85. Chinese Peptide Key News & Latest Developments
Table 86. Asymchem Lab Company Summary
Table 87. Asymchem Lab Polypeptide API Product Offerings
Table 88. Asymchem Lab Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 89. Asymchem Lab Key News & Latest Developments
Table 90. Aurisco Pharmaceutical Company Summary
Table 91. Aurisco Pharmaceutical Polypeptide API Product Offerings
Table 92. Aurisco Pharmaceutical Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 93. Aurisco Pharmaceutical Key News & Latest Developments
Table 94. BrightGene Bio-Medical Technology Company Summary
Table 95. BrightGene Bio-Medical Technology Polypeptide API Product Offerings
Table 96. BrightGene Bio-Medical Technology Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 97. BrightGene Bio-Medical Technology Key News & Latest Developments
Table 98. WuXi AppTec Company Summary
Table 99. WuXi AppTec Polypeptide API Product Offerings
Table 100. WuXi AppTec Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 101. WuXi AppTec Key News & Latest Developments
Table 102. Spera Nexus Company Summary
Table 103. Spera Nexus Polypeptide API Product Offerings
Table 104. Spera Nexus Polypeptide API Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2018-2023)
Table 105. Spera Nexus Key News & Latest Developments
Table 106. Polypeptide API Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 107. Global Polypeptide API Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Polypeptide API Production by Region, 2018-2023 (Tons)
Table 109. Global Polypeptide API Production by Region, 2024-2029 (Tons)
Table 110. Polypeptide API Market Opportunities & Trends in Global Market
Table 111. Polypeptide API Market Drivers in Global Market
Table 112. Polypeptide API Market Restraints in Global Market
Table 113. Polypeptide API Raw Materials
Table 114. Polypeptide API Raw Materials Suppliers in Global Market
Table 115. Typical Polypeptide API Downstream
Table 116. Polypeptide API Downstream Clients in Global Market
Table 117. Polypeptide API Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Polypeptide API Segment by Type in 2022
Figure 2. Polypeptide API Segment by Application in 2022
Figure 3. Global Polypeptide API Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Polypeptide API Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Polypeptide API Revenue, 2018-2029 (US$, Mn)
Figure 7. Polypeptide API Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Polypeptide API Revenue in 2022
Figure 9. By Type - Global Polypeptide API Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Polypeptide API Revenue Market Share, 2018-2029
Figure 11. By Type - Global Polypeptide API Sales Market Share, 2018-2029
Figure 12. By Type - Global Polypeptide API Price (US$/Kg), 2018-2029
Figure 13. By Application - Global Polypeptide API Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Polypeptide API Revenue Market Share, 2018-2029
Figure 15. By Application - Global Polypeptide API Sales Market Share, 2018-2029
Figure 16. By Application - Global Polypeptide API Price (US$/Kg), 2018-2029
Figure 17. By Region - Global Polypeptide API Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Polypeptide API Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Polypeptide API Revenue Market Share, 2018-2029
Figure 20. By Region - Global Polypeptide API Sales Market Share, 2018-2029
Figure 21. By Country - North America Polypeptide API Revenue Market Share, 2018-2029
Figure 22. By Country - North America Polypeptide API Sales Market Share, 2018-2029
Figure 23. US Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Polypeptide API Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Polypeptide API Sales Market Share, 2018-2029
Figure 28. Germany Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 29. France Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Polypeptide API Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Polypeptide API Sales Market Share, 2018-2029
Figure 37. China Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 41. India Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Polypeptide API Revenue Market Share, 2018-2029
Figure 43. By Country - South America Polypeptide API Sales Market Share, 2018-2029
Figure 44. Brazil Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Polypeptide API Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Polypeptide API Sales Market Share, 2018-2029
Figure 48. Turkey Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Polypeptide API Revenue, (US$, Mn), 2018-2029
Figure 52. Global Polypeptide API Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Polypeptide API by Region, 2022 VS 2029
Figure 54. Polypeptide API Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 無菌注射剤用調剤医薬品のグローバル市場展望 2023年-2029年：モノクローナル抗体、インスリン、免疫グロブリン、サイトカイン、血液因子、その他
  • 医薬品用発酵エンジニアリングのグローバル市場展望 2023年-2029年：モノクローナル抗体、抗生物質、インスリン、ヒト成長ホルモン、医薬品アミノ酸、その他
  • ペプチドAPIのグローバル市場展望 2023年-2029年：ホルモンポリスキン、抗体ポリペプチド、成長因子ポリペプチド、神経調節ポリペプチド、抗菌ペプチド
  • イオン交換装置のグローバル市場展望 2023年-2029年：装置、試薬、その他
  • 衣類＆繊維リサイクルのグローバル市場展望 2023年-2029年：衣類、靴、バッグ、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC15099 )"ポリペプチドAPIのグローバル市場展望 2023年-2029年：インスリン、非インスリン" (英文：Polypeptide API Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。